Sign in

CIK 0001356090

  • Non-accelerated filer
  • Smaller reporting company

PRECIGEN, INC.

Sign in to watch
Ticker
PGEN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
Phone
+1 301-556-9900
Business address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
Former names
INTREXON CORP
  1. 4 Exercise or conversion Chief Commercial Officer acquired 62,500 shares (option exercise)
  2. 4 Exercise or conversion Chief Operating Officer acquired 90,000 shares (option exercise)
  3. 4 Exercise or conversion President and CEO acquired 250,000 shares (option exercise)
  4. 4 Exercise or conversion Chief Legal Officer acquired 62,500 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Director sold 4,772,781 shares at $3.30 ($15,750,177)
  11. 4 Exercise or conversion Chief Financial Officer acquired 40,293 shares (option exercise)
  12. 4 Exercise or conversion Chief Commercial Officer acquired 42,110 shares (option exercise)
  13. 4 Exercise or conversion President and CEO acquired 321,100 shares (option exercise)
  14. 4 Exercise or conversion Chief Operating Officer acquired 44,495 shares (option exercise)
  15. 4 Exercise or conversion Chief Legal Officer acquired 40,443 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 143,678 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 71,839 shares (option exercise)
  18. 4 Exercise or conversion Director acquired 71,839 shares (option exercise)
  19. 4 Exercise or conversion Director acquired 71,839 shares (option exercise)
  20. 4 Exercise or conversion Director acquired 71,839 shares (option exercise)

Page 2 of 41 · 817 filings